|
Please type responses here: |
First name:
|
|
Last name:
|
|
Email Address:
|
|
Retype Email Address:
|
|
Phone number:
|
|
Institution:
|
|
Job title:
|
|
Address:
|
|
City:
|
|
State:
|
|
Country:
|
|
Zip/Postal Code:
|
|
What is your current role in healthcare?
|
Physician
Lab manager/director
Pathologist
POC coordinator
Nurse
Healthcare administrator
Other
|
If you responded with 'Other' above, what is your current role in healthcare?
|
|
When are you planning to implement new point of care cardiac diagnostic tools in your organization?
|
0 – 6 months
6 – 12 months
12 – 24 months
We don’t have any plans at this time
|
What is your organization’s current approach to using cardiac biomarkers in the emergency department? Please choose all that apply:
|
Single-marker strategy (e.g., only hs-Troponin or NT-proBNP)
Multi-marker strategy (e.g., using hs-Troponin, NT-proBNP, and/or D-Dimer together)
We currently do not use cardiac biomarkers in the ED
Exploring options to implement a new strategy
|
Where are your cardiac biomarkers (hsTnI, NT-proBNP, D-dimer) primarily processed?
|
Point-of-Care (POC) in the ED
Central Laboratory
Both POC and Central Laboratory
We do not currently use these biomarkers
|
By registering for this webinar, Whitehat uses your information to communicate with you regarding this webinar and other educational events. Please read our Privacy Policy (https://www.whitehatcom.com/privacy_policy.htm), which will be pertinent if you are based outside the United States.
|
Yes, I give my permission to receive communications from Whitehat, and I understand I may opt out at any time.
|
After clicking 'submit', you
will be redirected to the webinar recording.
You will also
receive an email with the link to the evaluation to fill out
after you finish the recording. |
|